BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹115 Cr | ₹85 Cr | ₹71 Cr | ₹42 Cr | ₹44 Cr |
What is the latest Revenue of BAFNA PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹115 Cr |
Mar2023 | ₹85 Cr |
Mar2022 | ₹71 Cr |
Mar2021 | ₹42 Cr |
Mar2020 | ₹44 Cr |
How is Revenue of BAFNA PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹115 Cr | 35.48 | |
Mar2023 | ₹85 Cr | 19.55 | |
Mar2022 | ₹71 Cr | 67.68 | |
Mar2021 | ₹42 Cr | -2.65 | |
Mar2020 | ₹44 Cr | - |
Compare Revenue of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹192.0 Cr | 1.3% | 1.3% | -8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 1.3% |
1.3% |
-8.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses